Blockage of Tumor Necrosis Factor α Versus CD80/86 Signaling on the Response to Influenza Vaccination of Rheumatoid Arthritis Patients

Jane Kasten-Jolly*; Nataliya Yuklyaeva; Jennifer Victory; Melissa Scribani; Erica Lasek-Nesselquist; Afeefa Shahnawaz; Donald Raddatz; David A. Lawrence

Blockage of Tumor Necrosis Factor α Versus CD80/86 Signaling on the Response to Influenza Vaccination of Rheumatoid Arthritis Patients

Research Article Volume 2 Issue 1

Jane Kasten-Jolly^*, Nataliya Yuklyaeva, Jennifer Victory, Melissa Scribani, Erica Lasek-Nesselquist, Afeefa Shahnawaz, Donald Raddatz and David A. Lawrence

Corresponding Author: Jane Kasten-Jolly

View PDF View Journal

Abstract

The objective of the study was to compare and characterize the response to the 2014/2015 season influenza vaccine in patients with Rheumatoid Arthritis (RA) receiving biological agents, either TNF α blockers or a T-cell activation blocker, abatacept

Article Information

Journal	SF Journal of Immunology
Article Type	Research Article
Volume	2
Issue	1